Reference number : 276-2021-2022-Q2-00044, amendment number : , agreement type : C, recipient legal name : TheraPBios Pharma Ltd.|TheraPBios Pharma Ltd., recipient country : CA, recipient province : NS, recipient city : Martock|Martock, recipient postal code : B0N 2T0, program name english : REGI - Business Scale-up and Productivity, program name french : CERI - Expansion et productivité des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 218722, agreement title french : 218722, agreement number : 218722, agreement value : 99000.0, agreement start date : 2021-07-17, agreement end date : 2022-07-31, description english : Adapt technology and scale up manufacturing for market introduction, description french : Adapter la technologie et accélérer la fabrication pour l’introduction sur le marché, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique